Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam + remifentanil vs propofol + remifentanil for painless bronchoscopy
ChiCTR2300069905Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Apr 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam, propofol and remifentanil in procedural pain and None (2 arms), sponsored by The First Hospital of Fujian Medical University. Primary endpoint: Incidence of intraoperative respiratory depression. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
remimazolampropofolremifentanil
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2300069905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069905.